Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization

The presence of anti-HLA antibodies is an increasing challenge in kidney transplantation. Tocilizumab (TCZ), a monoclonal antibody targeting the interleukin-6 receptor (IL-6R), has been proposed to complement conventional desensitization therapy. We aimed to describe TCZ plasma trough concentrations...

Descripción completa

Detalles Bibliográficos
Autores principales: Truffot, Aurélie, Jouve, Thomas, Noble, Johan, Bardy, Béatrice, Malvezzi, Paolo, Rostaing, Lionel, Stanke-Labesque, Françoise, Gautier-Veyret, Elodie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745611/
https://www.ncbi.nlm.nih.gov/pubmed/35011830
http://dx.doi.org/10.3390/jcm11010091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745611/
https://www.ncbi.nlm.nih.gov/pubmed/35011830
http://dx.doi.org/10.3390/jcm11010091

Ejemplares similares